UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UHS - US9139031002 - Common Stock
231.08 USD
+0.49 (+0.21%)
231.08 USD
0 (0%)
UHS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, UHS could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
UHS had positive earnings in the past year.
UHS had a positive operating cash flow in the past year.
Each year in the past 5 years UHS has been profitable.
UHS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
UHS has a Return On Assets of 8.96%. This is amongst the best in the industry. UHS outperforms 94.06% of its industry peers.
The Return On Equity of UHS (19.18%) is better than 88.12% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.33%, UHS belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.22%.
The 3 year average ROIC (8.28%) for UHS is below the current ROIC(12.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROIC | 12.33% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
UHS has a better Profit Margin (8.09%) than 88.12% of its industry peers.
In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
UHS has a better Operating Margin (11.47%) than 79.21% of its industry peers.
UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UHS has less shares outstanding than it did 1 year ago.
UHS has less shares outstanding than it did 5 years ago.
UHS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.24 indicates that UHS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.24, UHS is doing good in the industry, outperforming 68.32% of the companies in the same industry.
UHS has a debt to FCF ratio of 4.84. This is a neutral value as UHS would need 4.84 years to pay back of all of its debts.
UHS has a better Debt to FCF ratio (4.84) than 66.34% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
The Debt to Equity ratio of UHS (0.55) is better than 60.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | 3.24 |
ROIC/WACC1.51
WACC8.16%
2.3 Liquidity
A Current Ratio of 1.03 indicates that UHS should not have too much problems paying its short term obligations.
UHS's Current ratio of 1.03 is on the low side compared to the rest of the industry. UHS is outperformed by 70.30% of its industry peers.
UHS has a Quick Ratio of 1.03. This is a bad value and indicates that UHS is not financially healthy enough and could expect problems in meeting its short term obligations.
UHS has a worse Quick ratio (0.96) than 68.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.07% over the past year.
UHS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
Looking at the last year, UHS shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
UHS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
The Earnings Per Share is expected to grow by 13.53% on average over the next years. This is quite good.
UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.11, which indicates a very decent valuation of UHS.
Compared to the rest of the industry, the Price/Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 88.12% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of UHS to the average of the S&P500 Index (26.46), we can say UHS is valued rather cheaply.
UHS is valuated reasonably with a Price/Forward Earnings ratio of 9.92.
UHS's Price/Forward Earnings ratio is rather cheap when compared to the industry. UHS is cheaper than 91.09% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.11 | ||
| Fwd PE | 9.92 |
4.2 Price Multiples
81.19% of the companies in the same industry are more expensive than UHS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than the industry average as 75.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.91 | ||
| EV/EBITDA | 7.44 |
4.3 Compensation for Growth
UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UHS may justify a higher PE ratio.
A more expensive valuation may be justified as UHS's earnings are expected to grow with 15.88% in the coming years.
PEG (NY)0.39
PEG (5Y)1.03
EPS Next 2Y18.34%
EPS Next 3Y15.88%
5. Dividend
5.1 Amount
UHS has a yearly dividend return of 0.35%, which is pretty low.
Compared to an average industry Dividend Yield of 2.47, UHS pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.35, UHS pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
5.2 History
The dividend of UHS is nicely growing with an annual growth rate of 6.27%!
UHS has paid a dividend for at least 10 years, which is a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
UHS pays out 3.78% of its income as dividend. This is a sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
231.08
+0.49 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.46%
Inst Owner Change-2.3%
Ins Owners5.68%
Ins Owner Change16.62%
Market Cap14.44B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts71.54
Price Target252.79 (9.4%)
Short Float %3.61%
Short Ratio2.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)7.55%
PT rev (3m)12.15%
EPS NQ rev (1m)3.52%
EPS NQ rev (3m)4.2%
EPS NY rev (1m)2.74%
EPS NY rev (3m)3.25%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.11 | ||
| Fwd PE | 9.92 | ||
| P/S | 0.85 | ||
| P/FCF | 14.91 | ||
| P/OCF | 7.41 | ||
| P/B | 2.01 | ||
| P/tB | 4.54 | ||
| EV/EBITDA | 7.44 |
EPS(TTM)20.8
EY9%
EPS(NY)23.3
Fwd EY10.08%
FCF(TTM)15.5
FCFY6.71%
OCF(TTM)31.18
OCFY13.49%
SpS271.97
BVpS114.75
TBVpS50.9
PEG (NY)0.39
PEG (5Y)1.03
Graham Number231.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROCE | 16% | ||
| ROIC | 12.33% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 18.59% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A | ||
| FCFM | 5.7% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 162.72% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 15.36 | ||
| Cash Conversion | 76.35% | ||
| Profit Quality | 70.41% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 3.24 |
F-Score8
WACC8.16%
ROIC/WACC1.51
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year55.52%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
What is the valuation status for UHS stock?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for UHS stock?
The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 11.11 and the Price/Book (PB) ratio is 2.01.
Can you provide the financial health for UHS stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.